Upper Respiratory Tract Infection

Respiratory·MeSH: Respiration Disorders

Prevalence

2361.8 / 100K

Incidence

171074.6 / 100K/yr

4 drugs in development·3 companies·1 clinical trial

Drug Pipeline by Phase

Compare drugs

Andrographolide vs Double - Coptis SuppositoryAndrographolide vs erythromycin lactobionate

Frequently asked questions

How many drugs are in development for Upper Respiratory Tract Infection?

BioSniper tracks 4 drugs in development for Upper Respiratory Tract Infection across 3 companies.

How many clinical trials target Upper Respiratory Tract Infection?

There are 1 clinical trial targeting Upper Respiratory Tract Infection tracked by BioSniper.

What is the prevalence of Upper Respiratory Tract Infection?

The estimated prevalence of Upper Respiratory Tract Infection is approximately 2361.8 per 100,000 population.

Deep-dive into Upper Respiratory Tract Infection

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Upper Respiratory Tract Infection — Drugs in Development & Clinical Trials | BioSniper